INGN Inogen Inc

Price (delayed)

$26.16

Market cap

$597.38M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.87

Enterprise value

$409.8M

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental ...

Highlights
The revenue has increased by 15% year-on-year
The gross margin has grown by 7% YoY
The debt has grown by 36% year-on-year but it has declined by 3.2% since the previous quarter
Inogen's gross profit has increased by 23% YoY but it has decreased by 2.8% from the previous quarter
The quick ratio has contracted by 12% YoY and by 2.1% from the previous quarter
The equity has declined by 3.2% since the previous quarter

Key stats

What are the main financial stats of INGN
Market
Shares outstanding
22.84M
Market cap
$597.38M
Enterprise value
$409.8M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.66
Price to sales (P/S)
1.69
EV/EBIT
N/A
EV/EBITDA
21.18
EV/Sales
1.17
Earnings
Revenue
$351.46M
EBIT
-$2.95M
EBITDA
$19.34M
Free cash flow
-$20.35M
Per share
EPS
-$0.87
Free cash flow per share
-$0.89
Book value per share
$15.76
Revenue per share
$15.45
TBVPS
$16.86
Balance sheet
Total assets
$474.62M
Total liabilities
$116.33M
Debt
$25.81M
Equity
$358.29M
Working capital
$258.3M
Liquidity
Debt to equity
0.07
Current ratio
5.32
Quick ratio
4.3
Net debt/EBITDA
-9.7
Margins
EBITDA margin
5.5%
Gross margin
48.8%
Net margin
-5.6%
Operating margin
-0.6%
Efficiency
Return on assets
-4%
Return on equity
-5.3%
Return on invested capital
-2.2%
Return on capital employed
-0.7%
Return on sales
-0.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INGN stock price

How has the Inogen stock price performed over time
Intraday
-1.02%
1 week
4.93%
1 month
2.91%
1 year
-61.37%
YTD
-23.06%
QTD
-19.31%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$351.46M
Gross profit
$171.62M
Operating income
-$2.21M
Net income
-$19.82M
Gross margin
48.8%
Net margin
-5.6%
INGN's operating income has dropped by 124% since the previous quarter but it has surged by 82% year-on-year
The operating margin has plunged by 123% from the previous quarter but it has soared by 85% YoY
Inogen's gross profit has increased by 23% YoY but it has decreased by 2.8% from the previous quarter
The revenue has increased by 15% year-on-year

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
1.66
P/S
1.69
EV/EBIT
N/A
EV/EBITDA
21.18
EV/Sales
1.17
INGN's P/B is 73% below its 5-year quarterly average of 6.2 and 36% below its last 4 quarters average of 2.6
The equity has declined by 3.2% since the previous quarter
The stock's price to sales (P/S) is 70% less than its 5-year quarterly average of 5.7 and 40% less than its last 4 quarters average of 2.8
The revenue has increased by 15% year-on-year

Efficiency

How efficient is Inogen business performance
INGN's ROIC has plunged by 133% from the previous quarter but it has soared by 61% YoY
Inogen's ROS has plunged by 133% from the previous quarter but it has soared by 58% YoY

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
The quick ratio has contracted by 12% YoY and by 2.1% from the previous quarter
The company's current ratio fell by 4.7% YoY
The debt is 93% smaller than the equity
The debt to equity has increased by 40% YoY
The debt has grown by 36% year-on-year but it has declined by 3.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.